Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT03734237

A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD

Conditions: Influenza, Influenza-like Illness, Influenza Vaccines

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: PHASE4
Enrollment: 15448
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Location: Naval Medical Center San Diego San Diego California

Summary

A total of 18,000 eligible subjects (or 6,000 subject distributed evenly between the 3 study arms) will be enrolled. Eligible subjects will be randomized in 1:1:1 (cell-culture-based vaccine, the recombinant vaccine, or the egg-based vaccine) over four influenza seasons (2018-2019, 2019-2020, 2020-2021, and 2021-2022).

Eligibility Criteria

Inclusion Criteria: 1. Eligible for care in Department of Defense medical facilities (Defense Enrollment Eligibility Reporting System eligible) 2. ≥18 years of age. 3. At a participating Military Treatment Facility site for the purpose of receiving a seasonal (2018-2019, 2019-2020,2020-2021, 2021-2022) influenza vaccination. 4. Able to speak English and able to provide informed consent 5. Able to receive and respond to texts and/or emails, or a military recruit Exclusion Criteria: 1. Adults intending to receive or who have received the current seasons FluMist Vaccine (LAIV) 2. Adults who have already received a flu vaccine within the current season 3. Individual who cannot receive a flu vaccine or standard dosing due to another medical condition 4. Allergic to gentamicin, polymyxin and/or neomycin 5. Individuals who fail to meet the inclusion criteria

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03734237). StuddyBuddy aggregates publicly available trial information.